Tony Hagen, Senior Editor, The Center for Biosimilars

home / authors / tony-hagen-senior-editor-center-biosimilars

Articles

AMCP Nexus 2021: Cate Lockhart of Biologics and Biosimilars Collective Intelligence Consortium Discusses Biosimilars Such as Semglee and the Current Standing of Biosimilars, PBMs

AMCP Nexus 2021: Cate Lockhart of Biologics and Biosimilars Collective Intelligence Consortium Discusses Biosimilars Such as Semglee and the Current Standing of Biosimilars, PBMs

Tony Hagen, Senior Editor, The Center for Biosimilars
October 20th 2021

Cate Lockhart, Pharm.D., Ph.D., spoke at AMCP Nexus about biosimilars, the insulin biosimilar Semglee and the role of PBMs.

Read More

AMCP Nexus 2021: Jen Norton, VP & Head of U.S. Value & Access at Amgen Talks Biosimilar Trends and What to Expect in the Next Year

AMCP Nexus 2021: Jen Norton, VP & Head of U.S. Value & Access at Amgen Talks Biosimilar Trends and What to Expect in the Next Year

Tony Hagen, Senior Editor, The Center for Biosimilars
October 19th 2021

Jen Norton spoke at AMCP Nexus about biosimilar trends of 2021 and what to expect in the next 12 months

Read More

FDA Issues Contingency Guidance for Clinical Trials Affected by COVID-19

FDA Issues Contingency Guidance for Clinical Trials Affected by COVID-19

Tony Hagen, Senior Editor, The Center for Biosimilars
March 19th 2020

CROs are also adapting to pandemic.

Read More

Latest Updated Articles

Gaps in Diabetes Patient Education and Rising Healthcare Costs
Published: February 25th 2025 | Updated: February 28th 2025
Gaps in Diabetes Patient Education and Rising Healthcare Costs
black and white image of solders in jungle setting | ©daniel stock.adobe.com
Published: February 16th 2025 | Updated: February 19th 2025
Many Aging Vietnam War Vets Are Still Battling PTSD, Along With Chronic Illnesses, That Combat Exposure May Make More Likely, New Research Finds
food in heart shape with a stethoscope | image credit: ©udra11
Published: February 5th 2025 | Updated: February 7th 2025
A Key Ingredient to ‘Food is Medicine’: Standardization
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Published: January 30th 2025 | Updated: January 31st 2025
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
FDA Approved Bayer’s Nubeqa for Metastatic Castration-Sensitive Prostate Cancer
Published: June 5th 2025 | Updated: June 21st 2025
FDA Approved Bayer’s Nubeqa for Metastatic Castration-Sensitive Prostate Cancer
test tube in a lab | image credit: ©spyrakot stock.adobe.com
Published: May 7th 2025 | Updated: June 21st 2025
Depend on Biomarkers, Not Symptoms, for Diagnosis, Early Treatment of GVHD, Experts Argue
© 2025 MJH Life Sciences

All rights reserved.